These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8813577)

  • 1. Motor effects of lamotrigine in naive and dopamine-depleted mice.
    Kaur S; Starr M
    Eur J Pharmacol; 1996 May; 304(1-3):1-6. PubMed ID: 8813577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiparkinsonian action of dextromethorphan in the reserpine-treated mouse.
    Kaur S; Starr MS
    Eur J Pharmacol; 1995 Jul; 280(2):159-66. PubMed ID: 7589181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitation of dopamine D1 receptor- but not dopamine D1/D2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse.
    Starr MS; Starr BS
    Eur J Pharmacol; 1993 Dec; 250(2):239-46. PubMed ID: 7906652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice.
    Starr MS; Starr BS
    Psychopharmacology (Berl); 1994 Apr; 114(3):469-76. PubMed ID: 7855205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse.
    Starr BS; Starr MS; Kilpatrick IC
    Neuroscience; 1987 Jul; 22(1):179-88. PubMed ID: 2957609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.
    Starr MS; Starr BS
    Eur J Pharmacol; 1995 Apr; 277(2-3):151-8. PubMed ID: 7493603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor actions of eliprodil in the normal and monoamine-depleted mouse: a role in the treatment of Parkinson's disease?
    Brooks S; Kaur S; Starr BS; Starr MS
    J Neural Transm (Vienna); 1996; 103(6):737-48. PubMed ID: 8836935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of dopamine-dependent locomotion by clonidine in reserpine-treated mice is restricted to D2 agonists.
    Starr MS; Starr BS
    J Neural Transm Park Dis Dement Sect; 1994; 7(2):133-42. PubMed ID: 7710665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do NMDA receptor-mediated changes in motor behaviour involve nitric oxide?
    Starr MS; Starr BS
    Eur J Pharmacol; 1995 Jan; 272(2-3):211-7. PubMed ID: 7713165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of D1 receptor mechanisms in the potentiation of motor responses to L-dopa and apomorphine by MK 801 in the reserpine-treated mouse.
    Kaur S; Starr MS; Starr BS
    J Neural Transm Park Dis Dement Sect; 1994; 8(1-2):107-16. PubMed ID: 7893372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopamine receptor agonists on passive avoidance learning in mice: interaction of dopamine D1 and D2 receptors.
    Ichihara K; Nabeshima T; Kameyama T
    Eur J Pharmacol; 1992 Mar; 213(2):243-9. PubMed ID: 1355736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locomotor effects of amantadine in the mouse are not those of a typical glutamate antagonist.
    Starr MS; Starr BS
    J Neural Transm Park Dis Dement Sect; 1995; 9(1):31-43. PubMed ID: 7605588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of dopamine receptors in beneficial effects of tachykinins on scopolamine-induced impairment of alternation performance in mice.
    Ukai M; Shinkai N; Kameyama T
    Eur J Pharmacol; 1998 May; 350(1):39-45. PubMed ID: 9683012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate antagonists modify the motor stimulant actions of D1 and D2 agonists in reserpine-treated mice in complex ways that are not predictive of their interactions with the mixed D1/D2 agonist apomorphine.
    Starr MS; Starr BS
    J Neural Transm Park Dis Dement Sect; 1993; 6(3):215-26. PubMed ID: 7907216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine A1 receptor blockade selectively potentiates the motor effects induced by dopamine D1 receptor stimulation in rodents.
    Popoli P; Giménez-Llort L; Pezzola A; Reggio R; Martínez E; Fuxe K; Ferré S
    Neurosci Lett; 1996 Nov; 218(3):209-13. PubMed ID: 8945765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. l-DOPA promotes striatal dopamine release through D1 receptors and reversal of dopamine transporter.
    Viaro R; Longo F; Vincenzi F; Varani K; Morari M
    Brain Res; 2021 Oct; 1768():147583. PubMed ID: 34284020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
    Jackson DM; Mohell N; Bengtsson A; Malmberg A
    Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediation of dopamine D1 and D2 receptors in the effects of GBR 12909 on latent learning and locomotor activity in mice.
    Ichihara K; Nabeshima T; Kameyama T
    Eur J Pharmacol; 1993 Apr; 234(2-3):155-63. PubMed ID: 8097720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.